EVLO

0.00020.00%
AI

Andrea Itano

Head of Research

Dr. Andrea Itano Ph.D., has been Head of Research at Evelo Biosciences, Inc. since February 2020. Dr. Itano was Immuno-Inflammatory Disease Head and Senior Vice President at Evelo Biosciences, Inc. since July 10, 2017 until November 2018. Prior to Evelo, Dr. Itano was vice president and Head of the Tempero Discovery Performance Unit at GlaxoSmithKline, where she led a team of immunologists and chemists discovering and developing therapies for autoimmune and inflammatory diseases in the Treg and Th17 space. Dr. Itano also held group leader positions at Amgen and Roche and was CSO at Tempero Pharma, prior to its buyout by GlaxoSmithKline. She also completed a postdoctoral fellowship at the Center for Immunology at the University of Minnesota, Minneapolis. Dr. Itano received a B.A. in microbiology and immunology and a Ph.D. in immunology from the University of California, Berkeley.

Positions